Medical Devices Malaysia

Malaysia Rapid Antigen Tests Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Malaysia Rapid Antigen Tests Market Industry Trends and Forecast to 2034: Segmented by (Disease, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Malaysia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $14.1 Mn Placeholder estimate
Estimate 2025 $14.6 Mn 0.2% of the global market
Projected 2034 $19.4 Mn 32.8% Adds $4.8 Mn over 9 forecast years
CAGR 2025–2034 3.2% Faster than 0% of 173 Medical Devices markets here
Key players 5
  • Malaysia is 0.15% of the global market.
  • In APAC, the largest is China at $845.1 Mn.
  • Fastest growing: India at 6% a year.
  • Malaysia ranks 7th of 10 by size in APAC.

Market size projection

Malaysia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Rapid Antigen Tests Market market size by year, Malaysia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $14.1 Mn — —
2025 (base) $14.6 Mn +$0.5 Mn —
2026 (forecast) $15.1 Mn +$0.5 Mn +3.2%
2027 (forecast) $15.5 Mn +$0.5 Mn +6.5%
2028 (forecast) $16.0 Mn +$0.5 Mn +9.9%
2029 (forecast) $16.6 Mn +$0.5 Mn +13.4%
2030 (forecast) $17.1 Mn +$0.5 Mn +17.1%
2031 (forecast) $17.6 Mn +$0.5 Mn +20.8%
2032 (forecast) $18.2 Mn +$0.6 Mn +24.7%
2033 (forecast) $18.8 Mn +$0.6 Mn +28.7%
2034 (forecast) $19.4 Mn +$0.6 Mn +32.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $9.55 Bn
  2. North America $4.46 Bn
  3. US $4.37 Bn
  4. APAC $2.27 Bn
  5. Europe $1.73 Bn
  6. Canada $844.0 Mn
  7. China $845.1 Mn
  8. Japan $553.9 Mn
  9. Latin America $466.4 Mn
  10. Middle East $336.7 Mn
  11. Germany $297.9 Mn
  12. France $289.0 Mn
  13. UK $272.4 Mn
  14. Italy $242.9 Mn
  15. Brazil $246.7 Mn
  16. Ecuador $214.0 Mn
  17. Spain $173.8 Mn
  18. India $183.4 Mn
  19. Saudi Arabia $168.2 Mn
  20. Mexico $153.2 Mn
  21. Africa $142.8 Mn
  22. Australia $126.0 Mn
  23. New Zealand $99.5 Mn
  24. Russia $99.2 Mn
  25. South Africa $66.4 Mn
  26. UAE $49.1 Mn
  27. Egypt $30.3 Mn
  28. Philippines $18.2 Mn
  29. Malaysia (this report) $14.6 Mn
  30. Hong Kong $14.1 Mn
  31. Singapore $12.7 Mn
  32. Thailand $10.3 Mn
  33. Kenya $5.9 Mn

Report snapshot

Malaysia Rapid Antigen Tests Market Analysis at a glance
Market size, 2025$14.6 Mn placeholder estimate
Forecast, 2034$19.4 Mn placeholder estimate
Growth (CAGR), 2025–20343.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDisease and user (see all)
Key playersAbbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor, BD (Becton, Dickinson) (see all)
Regulator in MalaysiaMDASource: Medical Device Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Malaysia Rapid Antigen Tests Market Analysis Executive Summary

Rapid antigen tests detect proteins from viruses or bacteria in minutes, used for flu, COVID-19, strep throat and more.

Key segments of the rapid Antigen Tests market include disease (Influenza, COVID-19 and Strep A) and user (Professional and Self-Test).

Bar chart: Malaysia Rapid Antigen Tests market size, 2024–2034, placeholder estimates. $14.1 Mn in 2024, $14.6 Mn in 2025 and $19.4 Mn in 2034, 3.2% CAGR.
Malaysia Rapid Antigen Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Malaysia Rapid Antigen Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the rapid Antigen Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the rapid Antigen Tests market.

Competitive Landscape for Rapid Antigen Tests Market in Malaysia

The rapid Antigen Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Rapid Antigen Tests Market in Malaysia

Rapid Antigen Tests in Malaysia: rules and payment

Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012.⁠[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.⁠[2]

[1] Medical Device Authority. Checked 14 Nov 2026.

[2] Ministry of Health Malaysia. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how rapid Antigen Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Malaysia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Rapid Antigen Tests right now, from free public sources.

Latest research 571 papers since 2021 (worldwide)

  1. Diagnostic performance of antigen-based rapid test kits for six respiratory viruses in children: comparison with a multiplex PCR panel and correlation with viral load. Journal of clinical microbiology, 2026
  2. Frequency and etiological agents of acute gastroenteritis in children: a retrospective analysis before and during the COVID-19 pandemic. BMC infectious diseases, 2026
  3. A Kawasaki Disease-Like Presentation in a Child with Concurrent Detection of Group A Streptococcus and Adenovirus: A Case Report on the Characterization of Physical Findings and Short-Interval Reassessment. Reports (MDPI), 2026
  4. Diagnostic yield of reflex multiplex PCR after a negative rapid antigen test in children hospitalized with presumed viral acute respiratory tract infection: a prospective cohort study. Irish journal of medical science, 2026
  5. Viral Respiratory Infections: COVID-19. FP essentials, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Rapid Antigen Tests in context

Malaysia compared

  • Health spending per person: 450 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.34 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 6th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 8.0% of people (2025). World: 10.4% of people (2025). 8th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Rapid Antigen Tests market in Malaysia?
Placeholder estimate: about $14.6 Mn in 2025, rising to about $19.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Rapid Antigen Tests market in Malaysia growing?
Placeholder estimate: about 3.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Rapid Antigen Tests market report cover?
The report splits the market by disease (Influenza, COVID-19, Strep A, RSV and more) and user (Professional, Self-Test).
Who are the key players in the Rapid Antigen Tests market?
Key players include Abbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor and BD (Becton, Dickinson).
What is driving the Rapid Antigen Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.
Who regulates Rapid Antigen Tests in Malaysia?
Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012. Source: Medical Device Authority. Checked 14 Nov 2026.
How is healthcare paid for in Malaysia?
Public clinics and hospitals run by the Ministry of Health give heavily subsidised care. Source: Ministry of Health Malaysia. Checked 14 Nov 2026.
How much research is published on Rapid Antigen Tests?
PubMed lists 571 papers on Rapid Antigen Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Rapid Antigen Tests in Malaysia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Malaysia

See all
Same topic, other categories

Related on diagnostics and lab testing and infectious diseases

See the topic